Cargando…
Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study
| Autores principales: | , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503169/ https://www.ncbi.nlm.nih.gov/pubmed/37715280 http://dx.doi.org/10.1186/s13075-023-03158-9 |
| _version_ | 1785106469097570304 |
|---|---|
| author | Schett, Georg Chen, Warner Gao, Sheng Chakravarty, Soumya D. Shawi, May Lavie, Frederic Zimmermann, Miriam Sharaf, Mohamed Coates, Laura C. Siebert, Stefan |
| author_facet | Schett, Georg Chen, Warner Gao, Sheng Chakravarty, Soumya D. Shawi, May Lavie, Frederic Zimmermann, Miriam Sharaf, Mohamed Coates, Laura C. Siebert, Stefan |
| author_sort | Schett, Georg |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10503169 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-105031692023-09-16 Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study Schett, Georg Chen, Warner Gao, Sheng Chakravarty, Soumya D. Shawi, May Lavie, Frederic Zimmermann, Miriam Sharaf, Mohamed Coates, Laura C. Siebert, Stefan Arthritis Res Ther Correction BioMed Central 2023-09-15 2023 /pmc/articles/PMC10503169/ /pubmed/37715280 http://dx.doi.org/10.1186/s13075-023-03158-9 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Schett, Georg Chen, Warner Gao, Sheng Chakravarty, Soumya D. Shawi, May Lavie, Frederic Zimmermann, Miriam Sharaf, Mohamed Coates, Laura C. Siebert, Stefan Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study |
| title | Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study |
| title_full | Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study |
| title_fullStr | Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study |
| title_full_unstemmed | Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study |
| title_short | Correction: Effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the COSMOS phase 3b study |
| title_sort | correction: effect of guselkumab on serum biomarkers in patients with active psoriatic arthritis and inadequate response to tumor necrosis factor inhibitors: results from the cosmos phase 3b study |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10503169/ https://www.ncbi.nlm.nih.gov/pubmed/37715280 http://dx.doi.org/10.1186/s13075-023-03158-9 |
| work_keys_str_mv | AT schettgeorg correctioneffectofguselkumabonserumbiomarkersinpatientswithactivepsoriaticarthritisandinadequateresponsetotumornecrosisfactorinhibitorsresultsfromthecosmosphase3bstudy AT chenwarner correctioneffectofguselkumabonserumbiomarkersinpatientswithactivepsoriaticarthritisandinadequateresponsetotumornecrosisfactorinhibitorsresultsfromthecosmosphase3bstudy AT gaosheng correctioneffectofguselkumabonserumbiomarkersinpatientswithactivepsoriaticarthritisandinadequateresponsetotumornecrosisfactorinhibitorsresultsfromthecosmosphase3bstudy AT chakravartysoumyad correctioneffectofguselkumabonserumbiomarkersinpatientswithactivepsoriaticarthritisandinadequateresponsetotumornecrosisfactorinhibitorsresultsfromthecosmosphase3bstudy AT shawimay correctioneffectofguselkumabonserumbiomarkersinpatientswithactivepsoriaticarthritisandinadequateresponsetotumornecrosisfactorinhibitorsresultsfromthecosmosphase3bstudy AT laviefrederic correctioneffectofguselkumabonserumbiomarkersinpatientswithactivepsoriaticarthritisandinadequateresponsetotumornecrosisfactorinhibitorsresultsfromthecosmosphase3bstudy AT zimmermannmiriam correctioneffectofguselkumabonserumbiomarkersinpatientswithactivepsoriaticarthritisandinadequateresponsetotumornecrosisfactorinhibitorsresultsfromthecosmosphase3bstudy AT sharafmohamed correctioneffectofguselkumabonserumbiomarkersinpatientswithactivepsoriaticarthritisandinadequateresponsetotumornecrosisfactorinhibitorsresultsfromthecosmosphase3bstudy AT coateslaurac correctioneffectofguselkumabonserumbiomarkersinpatientswithactivepsoriaticarthritisandinadequateresponsetotumornecrosisfactorinhibitorsresultsfromthecosmosphase3bstudy AT siebertstefan correctioneffectofguselkumabonserumbiomarkersinpatientswithactivepsoriaticarthritisandinadequateresponsetotumornecrosisfactorinhibitorsresultsfromthecosmosphase3bstudy |